International Markets -- MEDICA Trade Fair

Drug-Cost: Anti-Malaria Drug Synthesised with Oxygen and Light

( Source: MEDICA.de )

[19/01/2012] It will be possible to provide medication for the 225 million malaria patients in developing countries at an affordable price. Researchers at the Max Planck Institute of Colloids and Interfaces in Potsdam have developed a very simple process for the synthesis of artemisinin, the active ingredient that pharmaceutical companies could only obtain from plants up to now. Drug-Cost: Anti-Malaria Drug Synthesised with Oxygen and Light - read more

Kidney Patients: Survival Rates in Germany are Better than in the U.S.

( Source: MEDICA.de )

[05/12/2011] In complex cases of kidney failure, medical care in Germany evidently operates better than in the United States. Scientists at Charité – Universitätsmedizin Berlin were able to show that German patients who have an increased risk of rejection reactions due to prior immunisation have better survival rates than people with diseases of similar severity in the US. Kidney Patients: Survival Rates in Germany are Better than in the U.S. - read more

Global Life Science: Hiring Index Reverses Growth Trend

( Source: MEDICA.de )

[23/11/2011] Global challenges in the general markets seem to have impacted hiring in the life sciences and health care sectors as the ZRG Partners GLSI index posted a 17.3 per cent decrease in overall hiring for the third quarter. Global Life Science: Hiring Index Reverses Growth Trend - read more

Duesseldorf: MEDICA 2011 + COMPAMED 2011 Start with a Record Number of Participants

( Source: MEDICA.de )

[11/11/2011] In the week ahead, from 16 - 19 November 2011, the attention of health and medical care professionals from around the world will once again focus on Düsseldorf, as the world's largest medical trade fair, MEDICA 2011, World Forum for Medicine, and COMPAMED 2011, High tech solutions for medical technology, the leading trade fair for the suppliers market in medical manufacturing, get underway. Duesseldorf: MEDICA 2011 + COMPAMED 2011 Start with a Record Number of Participants - read more

The European Enteral Feeds Market: What is everyone’s ‘Gut’ Feeling?

( Source: by Paljit Mudhar, Research Analyst, Frost & Sullivan )

[14/02/2006] Over the last twenty years, demand for enteral nutrition has risen rapidly. It is estimated that 30 per cent of all patients in Europe are malnourished. Clinical nutrition is divided into parenteral... The European Enteral Feeds Market: What is everyone’s ‘Gut’ Feeling? - read more

Diagnostic Related Groups: Driver or Threat for the Medical Device Industry?

( Source: By Eleni Grammenou, Research Analyst, Frost & Sullivan )

[09/01/2006] Over the last forty years, the health care industry has experienced rapid escalation in health care costs and medical spending. Today, in most of the western European countries, health care is one of... Diagnostic Related Groups: Driver or Threat for the Medical Device Industry? - read more

PACS - New Backbone of the Orthopaedic Medical Treatment Process

( Source: By Eleni Grammenou, Research Analyst, Frost & Sullivan )

[06/12/2005] The healthcare system is continuously faced with a number of challenges on the fiscal side, continuous pressures to reduce expenditure and curtail investment. Great emphasis is given to improve... PACS - New Backbone of the Orthopaedic Medical Treatment Process - read more

Orthopaedic Fixation: Past, Present and Future

( Source: Frost & Sullivan, Eleni Grammenou, Research Analyst )

[17/10/2005] Orthopaedic surgery was awakened as a speciality during World War I, and particularly driven by the units in Great Britain directed at the care of injured servicemen. The developments in orthopaedic... Orthopaedic Fixation: Past, Present and Future - read more

The Many Lives of Companies: J & J and Guidant Unite to Rule?

( Source: Frost & Sullivan, Kavitha Ravikumar, Industry Analyst )

[17/10/2005] Mergers and Acquisitions are shaking up the cardiology market. The market has seen innovations come in from start-ups and these start-ups have later been acquired by larger medical device companies... The Many Lives of Companies: J & J and Guidant Unite to Rule? - read more

Interview with Dr. Hilmar Janusson, V.P, Research & Development, Ossur

( Source: Frost & Sullivan )

[12/10/2005] Dr. Hilmar Janusson has been Vice President of Research & Development at Ossur in Reykjavik, Iceland since 1993. During that time, his team has helped Ossur introduce more innovations in prosthetic... Interview with Dr. Hilmar Janusson, V.P, Research & Development, Ossur - read more

Main content of this page

MEDICA

Main navigation

You are here: News. Business.